Skip to main content
Caprolactam Chemicals ltd. logo

Caprolactam Chemicals ltd. — Investor Relations & Filings

Ticker · 507486 ISIN · INE470N01010 BSE.NS Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2019-05-07 Regulatory Filings
Country IN India
Listing BSE.NS 507486

About Caprolactam Chemicals ltd.

https://www.caprolactam.co.in

Caprolactam Chemicals Ltd. specializes in the manufacturing and processing of chemical products, with a primary focus on the production and recovery of Caprolactam. The company operates a chemical plant equipped for distillation and purification processes, catering to the requirements of the synthetic fiber and plastics sectors. Its core activities involve the conversion of raw materials and chemical intermediates into high-quality industrial chemicals. Caprolactam Chemicals Ltd. leverages technical expertise in chemical engineering to provide essential components for the manufacturing of Nylon 6, engineering plastics, and various industrial resins. The company maintains a focus on operational efficiency and product quality to serve its diverse client base within the chemical manufacturing landscape.

Recent filings

Filing Released Lang Actions
closure of Trading window
Regulatory Filings Classification · 95% confidence The document contains two dated letters from the company Caprolactam Chemicals Limited addressed to the stock exchange (BSE Limited). The first letter dated April 3, 2019, announces the closure of the trading window for insiders until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2019. The second letter dated May 8, 2019, informs about the upcoming board meeting scheduled for May 30, 2019, to consider and approve the audited financial results for the quarter and year ended March 31, 2019, and to recommend dividend payment if any. The document does not contain the actual financial results or detailed financial data but rather announcements related to the timing of financial results and trading restrictions. The document length is only 2692 characters, which is short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about trading window closure and board meeting scheduling for financial results, not the financial report itself or earnings release.
2019-05-07 English
INTIMATION OF APPOINTMENT OF COMPANY SECRETARY CUM COMPLIANCE OFFICER.
Regulatory Filings
2019-04-30 English
Submission under Regulation 40(9) certificate for Practicing Company Secretary
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended March 31, 2019. It is signed by a Practicing Company Secretary and certifies the timely issuance of share certificates related to share transfers during the specified period. The document includes detailed annexure data about share transfers and related dates. This is a compliance certificate related to share transfer processes and not a financial report, earnings release, or management discussion. It is not an announcement of a report but the certificate itself. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and does not fall under other more specific categories.
2019-04-30 English
INTIMATION OF ISSUE OF DUPLICATE SHARE CERTIFICATE
Regulatory Filings
2019-03-29 English
INTIMATION OF ISSUE OF DUPLICATE SHARE CERTIFICATE
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Bombay Stock Exchange Limited regarding the issue of duplicate share certificates due to loss or misplacement. It references Regulation 39(3) of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, which pertains to share certificate management. The content is about notifying the stock exchange of the issuance of duplicate share certificates for a shareholder. This is not a financial report, earnings release, or management discussion, but rather a regulatory compliance notification related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-03-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.